跳至主要内容
临床试验/JPRN-UMIN000027465
JPRN-UMIN000027465已完成未知

Efficacy and safety of the biosimilar Infliximab in the patients with ulcerative colitis - Efficacy and safety of IFX-BS in UC patients

niversity of Toyama0 个研究点目标入组 20 人开始时间: 2017年5月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients younger than 20 years old 2) Patients keeping in the clinical remission state for more than 10 years

研究者

发起方
niversity of Toyama

相似试验

已完成
不适用
Efficacy and safety of the biosimilar Infliximab in the patients with Crohn's diseaseCrohn disease
JPRN-UMIN000026330niversity of Toyama18
已完成
不适用
Current Status of the Effectiveness of Infliximab with Ulcerative colitis-A prospective observational study of serum Infliximab consentrationsulcerative colitis
JPRN-UMIN000026006Kitasato University20
已完成
不适用
Current Status of the Effectiveness of Infliximab with Crohn's disease-A prospective observational study of serum Infliximab consentrationss diseaseCrohn's disease
JPRN-UMIN000028343Kitasato University School of Medicine12
进行中(未招募)
不适用
Comparison of the Efficacy and Safety of Infliximab, as Monotherapy or in Combination With Azathioprine, Versus Azathioprine Monotherapy in Moderate to Severe Active Ulcerative Colitis (Part 1) Comparison of Maintenance Versus Intermittent Infliximab Treatment in Maintaining Remission: A Follow-Up of Efficacy and Safety (Part 2)moderately to severely active Ulcerative ColitisMedDRA version: 14.1Level: PTClassification code 10009900Term: Colitis ulcerativeSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2006-002670-22-ITSCHERING-PLOUGH600
进行中(未招募)
1 期
EFFICACI : EFFicacy of intravenous Infliximab versus vedolizumab after failure of subCutaneous Anti-TNF in patients with UlCerative colitis : A double blinded Randomized Clinical Trial.lcerative colitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856
EUCTR2018-002673-21-FRCentre Hospitalier Universitaire de Rennes150
Efficacy and safety of the biosimilar Infliximab in... | 临床试验